Free shipping on all orders over $ 500

B7/CD28 interaction inhibitor 1

Cat. No. M9730

All AbMole products are for research use only, cannot be used for human consumption.

B7/CD28 interaction inhibitor 1 Structure
Synonym:

ABM-24720; CTLA-4 - inhibitor

Size Price Availability
5mg USD 230  USD230 4-7 Days
10mg USD 380  USD380 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

B7/CD28 interaction inhibitor 1 is a potent B7.1-CD28 interaction inhibitor with IC50 of 50 nM. Blocking B7/CD28 interactions with monoclonal antibodies or soluble receptors results in immunosuppression and enhanced allograft survival, while B7/CTLA-4 blockade results in enhanced antitumor immune responses. The interaction of co-stimulatory molecules on T cells with B7 molecules on antigen presenting cells plays an important role in the activation of naive T cells.

Chemical Information
Molecular Weight 427.35
Formula C21H13F4N5O
CAS Number 635324-72-0
Form Solid
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Neal J Green, et al. Bioorg Med Chem. Structure-activity studies of a series of dipyrazolo[3,4-b:3',4'-d]pyridin-3-ones binding to the immune regulatory protein B7.1

Related Immunology/Inflammation Products
Qingdainone

Qingdainone is a natural product that can be obtained from Qingdai. Qingdainone has the potential to study cancer and inflammation

IA9 TFA

IA9 TFA is a TREM-2 inhibitor. IA9 TFA and can diminish release of proinflammatory cytokines and dramatically suppressed joint inflammation and damage in collagen-Induced Arthritis (CIA) mice model.

Thymosin alpha 1

Thymosin alpha 1 (Tα1), a 28-amino acid peptide, is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function. Thymosin alpha 1 (Tα1) can enhance T-cell, dendritic cell (DC) and antibody responses, modulate cytokines and chemokines production and block steroid-induced apoptosis of thymocytes.

Lintuzumab

Lintuzumab is a humanized monoclonal antibody directed against CD33, which is expressed on the majority of myeloblasts in acute myeloid leukemia.

Evorpacept

Evorpacept (ALX148) is a high affinity CD47-blocking fusion protein with an inactive human immunoglobulin Fc region designed to enhance the activity of other anti-neoplastic therapies, with minimal additional toxicity.

  Catalog
Abmole Inhibitor Catalog




Keywords: B7/CD28 interaction inhibitor 1, ABM-24720; CTLA-4 - inhibitor supplier, Immunology/Inflammation, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.